MudraJKapoorMD

Physician

Dr. Kapoor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

9 citations
Relationship of Initial Pancreatic Enzyme Replacement Therapy Dose With Weight Gain in Infants With Cystic Fibrosis.
Michael S. Schechter, Suzanne H. Michel, Shufang Liu, B Woun Seo, Mudra Kapoor
Journal of Pediatric Gastroenterology and Nutrition. 2018-10-01
53 citations
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials.
Gregory J. Dore, Brian Conway, Yan Luo, Ewa Janczewska, Brygida Knysz
Journal of Hepatology. 2016-01-01
35 citations
Exploratory trial of ombitasvir and ABT-450/r with or without ribavirin for HCV genotype 1, 2, and 3 infection
Eric Lawitz, Greg Sullivan, Maribel Rodriguez-Torres, Michael J. Bennett, Fred Poordad
The Journal of Infection. 2015-02-01

AbbVie to Showcase Migraine Portfolio and Pipeline During the 16th European Headache Federation CongressDecember 6th, 2022
AbbVie to Present Data from Growing Neuroscience and Movement Disorders Portfolio at 2022 MDS International CongressSeptember 15th, 2022
New Long-Term Efficacy and Safety Analyses Evaluating RINVOQ® (Upadacitinib) in Patients with Rheumatoid Arthritis to Be Presented at EULAR 2021 Virtual CongressJune 2nd, 2021
Join now to see all